Article Details

Novo's $3.3bn GalXC quest | Evaluate

Retrieved on: 2021-11-18 16:06:09

Tags for this article:

Click the tags to see associated articles and topics

Novo's $3.3bn GalXC quest | Evaluate. View article details on hiswai:

Excerpt

But much of Dicerna's pipeline is entailed elsewhere, with the company collaborating with Roche, Lilly and Alexion, among others.

Article found on: www.evaluate.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up